Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 44.65
Bid: 44.80
Ask: 44.95
Change: -0.75 (-1.65%)
Spread: 0.15 (0.335%)
Open: 47.00
High: 47.00
Low: 44.65
Prev. Close: 44.65
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

9 Dec 2021 17:47

RNS Number : 1964V
IP Group PLC
09 December 2021
 

IP GROUP plc (the "Company")

 

Transaction in Own Shares

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), today announces that Numis Securities Limited purchased on behalf of IP Group the number of ordinary shares of 2 pence each on the London Stock Exchange as set out in the table below (the Repurchased Shares) pursuant to the IP Group share buyback programme announced on 8 October 2021 (the Buyback Programme).

Date of purchase:

09-Dec-21

Number of ordinary shares purchased:

250,000

Highest price paid per ordinary share (GBp):

120.00

Lowest price paid per ordinary share (GBp):

118.20

Volume weighted average price paid per ordinary share (GBp):

119.5266

The Group will hold the Repurchased Shares in treasury. Following the above transaction, the Group holds 19,782,105 of its ordinary shares in treasury and has 1,063,033,287 ordinary shares in issue (including treasury shares). Therefore, the total number of ordinary shares with voting rights will be 1,043,251,182 which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, IP Group under the FCA's Disclosure Guidance and Transparency Rules.

 

IP Group will make further announcements following the completion of any additional purchases pursuant to the Buyback Programme.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made by Numis Securities Limited on behalf of IP Group as part of the Buyback Programme.

 

Both aggregate data in respect of the Repurchased Shares as well as the individual purchases are set out below.

 

Aggregate information:

 

Issuer name and ISIN: IP Group plc (ISIN: GB00B128J450)

 

Date of purchases:

09 December 2021

Number of ordinary shares purchased:

250,000

Volume weighted average price (pence):

119.5266

Individual transactions:

 

Number of sharespurchased

Transaction price(per share)

Time of transaction

Trading venue

1671

118.20

 08:14:03

LSE

2500

119.60

 09:21:05

LSE

2500

119.60

 09:21:05

LSE

1660

119.60

 09:21:05

LSE

2500

119.60

 09:21:06

LSE

1454

119.60

 09:21:06

LSE

7204

119.40

 09:21:07

LSE

604

119.40

 09:21:07

LSE

7476

120.00

 09:22:53

LSE

556

120.00

 09:22:53

LSE

2800

120.00

 09:22:53

LSE

4557

120.00

 09:23:10

LSE

8061

119.80

 09:24:02

LSE

4049

119.80

 09:39:02

LSE

2900

119.80

 09:39:02

LSE

2972

119.60

 10:03:40

LSE

288

119.60

 10:03:43

LSE

2500

119.60

 10:03:43

LSE

8288

119.60

 10:03:43

LSE

1006

119.60

 10:03:43

LSE

6860

119.40

 10:21:02

LSE

898

119.20

 11:27:11

LSE

3

119.20

 11:27:11

LSE

2510

119.20

 11:28:23

LSE

2500

119.20

 11:28:23

LSE

2500

119.20

 11:43:23

LSE

2930

119.20

 11:51:23

LSE

2500

119.20

 11:51:23

LSE

2500

119.20

 12:01:46

LSE

1649

119.20

 12:10:46

LSE

750

119.20

 12:10:46

LSE

378

119.20

 12:10:46

LSE

2500

119.20

 12:10:46

LSE

1912

119.20

 12:26:23

LSE

379

119.20

 12:32:23

LSE

2500

119.20

 12:32:23

LSE

4802

119.00

 12:40:04

LSE

1910

119.00

 12:40:04

LSE

1216

119.00

 12:40:04

LSE

6696

119.00

 12:40:04

LSE

53

119.40

 12:54:24

LSE

7178

119.40

 12:54:24

LSE

7

119.60

 12:55:23

LSE

26

119.60

 12:58:45

LSE

281

119.60

 13:00:11

LSE

2154

119.60

 13:00:11

LSE

12

119.60

 13:00:11

LSE

3116

119.60

 13:00:11

LSE

1504

119.60

 13:00:11

LSE

1000

119.60

 13:00:11

LSE

158

119.60

 13:00:11

LSE

16

119.60

 13:12:35

LSE

8064

119.60

 13:23:58

LSE

271

119.60

 13:23:58

LSE

5431

119.60

 13:23:58

LSE

2500

119.60

 13:23:58

LSE

7259

119.40

 13:45:03

LSE

2500

119.60

 14:30:12

LSE

2500

119.60

 14:30:12

LSE

1940

119.60

 14:30:12

LSE

2500

119.60

 14:30:12

LSE

6918

119.60

 14:44:12

LSE

1135

119.60

 14:44:12

LSE

1531

119.60

 14:53:10

LSE

2500

119.60

 14:53:10

LSE

2530

119.60

 14:56:10

LSE

301

119.60

 14:56:10

LSE

1645

119.60

 14:56:10

LSE

2500

119.60

 14:56:10

LSE

8161

119.60

 15:18:11

LSE

3400

119.60

 15:25:58

LSE

2500

119.60

 15:25:58

LSE

5202

119.40

 15:28:07

LSE

1723

119.40

 15:28:07

LSE

8321

119.60

 15:45:31

LSE

6060

119.60

 16:17:50

LSE

6904

119.60

 16:17:50

LSE

6813

119.60

 16:17:50

LSE

7729

119.60

 16:17:50

LSE

7826

119.60

 16:17:51

LSE

907

119.60

 16:17:51

LSE

2990

120.00

 16:27:53

LSE

495

120.00

 16:27:53

LSE

 

For more information, please contact:

IP Group plc

www.ipgroupplc.com

Liz Vaughan-Adams, Communications

+44 (0) 20 7444 0062/+44 (0) 7979 853802

Charlotte Street Partners

David Gaffney

+44 (0) 7854 609998

Andrew Wilson

+44 (0) 7810 636995

 

Further information on IP Group is available on our website: www.ipgroupplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSDZMGZNLVGMZM
Date   Source Headline
12th Nov 20157:10 amRNSPortfolio company Xeros announces £40m funding
10th Nov 20157:00 amRNSUS Technology Summit
2nd Nov 201510:05 amRNSTotal Voting Rights
2nd Nov 20157:00 amRNSPortfolio company Ultrahaptics raises £10.1m
19th Oct 20157:00 amRNSIssue of Equity
1st Oct 20157:00 amRNSHolding(s) in Company
28th Sep 201510:02 amRNSHolding(s) in Company
8th Sep 20154:09 pmRNSDirector/PDMR Shareholding
4th Sep 201511:36 amRNSDirector/PDMR Shareholding
14th Aug 20157:00 amRNSPortfolio company First Light raises £22.7m
5th Aug 20157:00 amRNSHalf Yearly Report
30th Jul 20157:01 amRNSDirectorate Change
21st Jul 20157:09 amRNSOxford Nanopore announces £70m fundraising
15th Jul 20157:18 amRNSPortfolio co Avacta announces £22m funding round
9th Jul 20157:00 amRNSNew £30m debt facility
19th Jun 20158:05 amRNSOSI plc closes funding of £320m partnership
29th May 20159:33 amRNSTotal Voting Rights
22nd May 201511:03 amRNSDirector/PDMR Shareholding
21st May 20156:11 pmRNSHolding(s) in Company
21st May 20159:51 amRNSHolding(s) in Company
14th May 20154:05 pmRNSResults of Placing
14th May 20157:00 amRNSInvestment in OSI and proposed placing
12th May 20154:21 pmRNSResult of AGM
12th May 20157:00 amRNSAGM Statement
23rd Apr 20155:48 pmRNSHolding(s) in Company
16th Apr 20151:33 pmRNSHolding(s) in Company
10th Apr 20159:38 amRNSNotice of AGM; Annual Report
2nd Apr 201511:11 amRNSHolding(s) in Company
31st Mar 20156:23 pmRNSTotal Voting Rights
31st Mar 20156:19 pmRNSDirector/PDMR Shareholding
30th Mar 20157:00 amRNSDiurnal commences Phase 3 trial for Infacort
27th Mar 20157:00 amRNSResult of Capital Raising
26th Mar 20155:25 pmRNSResult of Open Offer
26th Mar 201511:30 amRNSResult of General Meeting
25th Mar 20159:31 amRNSHolding(s) in Company
25th Mar 20157:00 amRNSDiurnal granted Orphan Drug designation in the US
23rd Mar 20154:20 pmRNSDirector Declaration
10th Mar 20155:06 pmRNSPublication of Prospectus
10th Mar 20157:04 amRNSCapital Raising
10th Mar 20157:03 amRNSFinal Results
22nd Jan 20155:24 pmRNSPortfolio company Tissue Regenix raises £20m
31st Dec 20147:00 amRNSCompletes first spin-out from Penn
27th Nov 20147:00 amRNSMBS announces collaboration worth up to £176m
26th Nov 20147:00 amRNSPortfolio company Genomics raises £10.3m
20th Nov 20147:00 amRNSModern Biosciences wins £2.4m award
18th Nov 201412:44 pmRNSHolding(s) in Company
13th Nov 20147:00 amRNSInterim Management Statement
6th Nov 20147:00 amRNSLaunch of US commercialisation initiative
29th Oct 20147:00 amRNSDirectorate Change
5th Sep 20147:00 amRNSNotification of Major Interest in Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.